[1] World Health Organization. Evidence, policy, impact: WHO guide for evidence-informed decision-making. World Health Organization. 2022.
[2] Robine JM, Jagger C. Creating a coherent set of indicators to monitor health across Europe: the Euro-REVES 2 project. Eur J Public Health, 2003; 13, 6−14. doi:  10.1093/eurpub/13.suppl_1.6
[3] Saito Y, Robine JM, Crimmins EM. The methods and materials of health expectancy. Stat J IAOS, 2014; 30, 209−23. doi:  10.3233/SJI-140840
[4] Arora VS, Karanikolos M, Clair A, et al. Data resource profile: the European Union Statistics on income and living conditions (EU-SILC). Int J Epidemiol, 2015; 44, 451−61. doi:  10.1093/ije/dyv069
[5] Hintzpeter B, Finger JD, Allen J, et al. European health interview survey (EHIS) 2 - background and study methodology. J Health Monit, 2019; 4, 66−79.
[6] Börsch-Supan A, Brandt M, Hunkler C, et al. Data resource profile: the survey of health, ageing and retirement in Europe (SHARE). Int J Epidemiol, 2013; 42, 992−1001. doi:  10.1093/ije/dyt088
[7] Madans JH, Weeks JD. A framework for monitoring progress using summary measures of health. J Aging Health, 2016; 28, 1299−314. doi:  10.1177/0898264316656510
[8] Overall health and well-being measures. https://health.gov/healthypeople/objectives-and-data/overall-health-and-well-being-measures.
[9] Chen PJ, Li FZ, Harmer P. Healthy China 2030: moving from blueprint to action with a new focus on public health. Lancet Public Health, 2019; 4, E447. doi:  10.1016/S2468-2667(19)30160-4
[10] Tsuji I. Current status and issues concerning health Japan 21 (second term). Nutr Rev, 2020; 78, 14−7. doi:  10.1093/nutrit/nuaa079
[11] Oksuzyan A, Brønnum-Hansen H, Jeune B. Gender gap in health expectancy. Eur J Ageing, 2010; 7, 213−8. doi:  10.1007/s10433-010-0170-4
[12] Di Lego V, Lazarevič P, Luy M. The male-female health-mortality paradox. In: Gu D, Dupre ME. Encyclopedia of Gerontology and Population Aging. Springer. 2019, 1-8.
[13] Nusselder WJ, Looman CWN. Decomposition of differences in health expectancy by cause. Demography, 2004; 41, 315−34. doi:  10.1353/dem.2004.0017
[14] Andreev EM, Shkolnikov V, Begun A. Algorithm for decomposition of differences between aggregate demographic measures and its application to life expectancies, healthy life expectancies, parity-progression ratios and total fertility rates. Demogr Res, 2002; 7, 499−522. doi:  10.4054/DemRes.2002.7.14
[15] Banham D, Woollacott T, Lynch J. Healthy life gains in South Australia 1999-2008: analysis of a local Burden of Disease series. Popul Health Metr, 2011; 9, 13. doi:  10.1186/1478-7954-9-13
[16] Yokota RTC, Nusselder WJ, Robine JM, et al. Contribution of chronic conditions to gender disparities in health expectancies in Belgium, 2001, 2004 and 2008. Eur J Public Health, 2019; 29, 82−7. doi:  10.1093/eurpub/cky105
[17] Zhao Y, Unnikrishnan R, Chondur R, et al. Decomposing the gaps in healthy and unhealthy life expectancies between Indigenous and non-Indigenous Australians: a burden of disease and injury study. Popul Health Metr, 2024; 22, 15. doi:  10.1186/s12963-024-00335-z
[18] Chen H, Chen G, Zheng XY, et al. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study. BMJ, 2019; 364, l969.
[19] GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024; 403, 2100−32. doi:  10.1016/S0140-6736(24)00367-2
[20] Zhao YH, Hu YS, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol, 2014; 43, 61−8. doi:  10.1093/ije/dys203
[21] Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA, 1963; 185, 914−9. doi:  10.1001/jama.1963.03060120024016
[22] Chen TQ, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. Association for Computing Machinery. 2016, 785-94.
[23] Liu Y, Allan, J. SHAPforxgboost: SHAP Plots for 'XGBoost'. R package version 0.1. 0. https://github.com/liuyanguu/SHAPforxgboost/.
[24] World Health Organization. Evidence, policy, impact: WHO guide for evidence-informed decision-making. World Health Organization. 2022.
[25] Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol, 2019; 16, 203−12. doi:  10.1038/s41569-018-0119-4
[26] Wan H, Li Y, Liu J, et al. [The epidemiology of out-of-hospital deaths due to acute coronary events in young Beijing adults]. Zhonghua Nei Ke Za Zhi, 2012; 51, 274−8.
[27] Gao YL, Su JT, Wei ZH, et al. [Characteristics of out-of-hospital acute coronary heart disease deaths of Beijing permanent residents at the age of 25 or more from 2007 to 2009]. Zhonghua Xin Xue Guan Bing Za Zhi, 2012; 40, 199−203.
[28] Zhao D. [The epidemiology of coronary heart disease (CHD) in 16 provinces of China. multi-province cooperative group of cardiovascular disease surveillance (MONICA Project)]. Zhonghua Liu Xing Bing Xue Za Zhi, 1993; 14, 10−3.
[29] Jia WP, Chan JC, Wong TY, et al. Diabetes in China: epidemiology, pathophysiology and multi-omics. Nat Metab, 2025; 7, 16−34. doi:  10.1038/s42255-024-01190-w
[30] Jia WP. Diabetes care in China: innovations and implications. J Diabetes Invest, 2022; 13, 1795−7. doi:  10.1111/jdi.13908
[31] Xia X, Cai Y, Cui X, et al. Temporal trend in mortality of cardiovascular diseases and its contribution to life expectancy increase in China, 2013 to 2018. Chin Med J, 2022; 135, 2066−75. doi:  10.1097/CM9.0000000000002082
[32] Wu SM, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol, 2019; 18, 394−405. doi:  10.1016/S1474-4422(18)30500-3
[33] Asakawa T, Zong L, Wang L, et al. Unmet challenges for rehabilitation after stroke in China. Lancet, 2017; 390, 121−2.
[34] Patwardhan V, Gil GF, Arrieta A, et al. Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Public Health, 2024; 9, E282−94. doi:  10.1016/S2468-2667(24)00053-7
[35] Pang HW, Chen SH, Klyne DM, et al. Low back pain and osteoarthritis pain: a perspective of estrogen. Bone Res, 2023; 11, 42. doi:  10.1038/s41413-023-00280-x
[36] Liu LY. Major challenges and solutions of deepening health system reforms. Adm Reform, 2024; 11, 4−12. (In Chinese)
[37] Lancet T. A tiered health-care delivery system for China. Lancet, 2019; 393, 1178.
[38] Healthy China: deepening health reform in China: building high-quality and value-based service delivery (Chinese). Washington: World Bank Group, http://documents.worldbank.org/curated/en/295711578038265140/Building-High-Quality-and-Value-Based-Service-Delivery.
[39] Wang X, Sun XZ, Gong FF, et al. The Luohu Model: a template for integrated urban healthcare systems in China. Int J Integr Care, 2018; 18, 3.
[40] Wang X, Sun XZ, Birch S, et al. People-centred integrated care in urban China. Bull World Health Organ, 2018; 96, 843−52. doi:  10.2471/BLT.18.214908
[41] Liang D, Mei L, Chen YY, et al. Building a people-centred integrated care model in urban China: a qualitative study of the health reform in Luohu. Int J Integr Care, 2020; 20, 9.
[42] Liu FY, Liu FC, Lin JC, et al. The early impact of the people-centred integrated care on the hypertension management in Shenzhen. Int J Integr Care, 2023; 23, 6.
[43] 健康中国行动推进委员会. 健康中国行动(2019—2030年). https://www.gov.cn/xinwen/2019-07/15/content_5409694.htm. (查阅网上资料,未找到本条文献引用日期信息,请确认) (查阅所有网上资料,未找到本条文献英文翻译,请确认)
[44]

Tu WJ, Zhao ZP, Yin P, et al. Estimated burden of stroke in China in 2020. JAMA Netw Open, 2023; 6, e231455. doi:  10.1001/jamanetworkopen.2023.1455
[45]

Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U. S. deaths from coronary disease, 1980-2000. N Engl J Med, 2007; 356, 2388−98. doi:  10.1056/NEJMsa053935
[46]

Critchley J, Liu J, Zhao D, et al. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation, 2004; 110, 1236−44. doi:  10.1161/01.CIR.0000140668.91896.AE
[47]

Cleeman JI, Lenfant C. The national cholesterol education program. JAMA, 1998; 280, 2099−104. doi:  10.1001/jama.280.24.2099
[48]

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med, 1988; 148, 36-69.
[49]

Li JJ, Zhao SP, Zhao D, et al. 2023 China guidelines for lipid management. J Geriatr Cardiol, 2023; 20, 621−63. doi:  10.26599/1671-5411.2023.09.008
[50]

Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science, 2012; 337, 1499−501. doi:  10.1126/science.1223466
[51]

Wan X, Yang GH. Is the mortality trend of ischemic heart disease by the GBD2013 study in China real?. Biomed Environ Sci, 2017; 30, 204−9.
[52]

GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet, 2024; 403, 1989−2056. doi:  10.1016/S0140-6736(24)00476-8
[53]

Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health, 2015; 3, e712−23. doi:  10.1016/S2214-109X(15)00069-8
[54]

Liu XX, Wang F, Yu CH, et al. Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study. Lancet Reg Health West Pac, 2022; 26, 100520.